Abstract:BACKGROUND: Hepatitis B virus (HBV) is a hepatotropic, noncytopathic, DNA virus which can cause acute and chronic infection. Viral persistence is associated with a weak or absent specific immune responses to HBV, particularly the cellular immune response. Dendritic cells (DCs) are professional antigen-presenting cells with a unique T cell stimulatory aptitude that play a crucial role in the instruction of adaptive immune responses upon infection. An impaired function of DCs was suggested by recent studies to account for the T and B cell hyporesponsiveness in chronic HBV infection. This review summarizes recent insights into the recognition of HBV antigens by DCs. DATA SOURCES: Studies were identified by searching MEDLINE and/or PubMed for articles using the key words "hepatitis B virus (HBV)", "dendritic cells", "C-type lectins", "mannose receptor", "toll-like receptor", and "dendritic cell-specific intercellular-adhesion-molecule-3 grabbing nonintegrin (DC-SIGN)" up to December 2009. Additional papers were identified by a manual search of the references from the key articles. RESULTS: DCs play an important role in the progress of hepatitis B, especially in the recognition of HBV. There are three main ways of recognition of HBV antigens by DCs. First, HBV DNA can be recognized by DCs through toll-like receptor 9 (TLR9) which activates the NF-kappa B signal pathway and p38 MAPK to up-regulate the expression of interferon (IFN) regulatory factor 7 (IRF-7) in a manner independent of type I IFN signaling, resulting in secretion of type I IFN and inflammatory cytokines, and induction of DC maturation and the adaptive immune response. Second, HBc/HBeAg cannot be recognized by DCs, but DNA or ssRNA encapsulated within HBcAg can be internalized by DCs through TLRs. Third, HBsAg can be internalized by DCs through the mannose receptor, which lacks the ability to induce DC maturation without the assistance of DC-SIGN. Meanwhile, there is some cross-talk among the three mechanisms, which induces an effective anti-viral response or HBV persistence. CONCLUSIONS: On the basis of these recognition processes, methods have been used to enhance the efficacy of DC-based vaccine against HBV and have been useful in the clinical application of HBV vaccine therapy. But the interactions between HBV antigens/HBV DNA and DCs are not clear, and cross-talk between TLRs and various ligands makes HBV antigen recognition by DCs more complicated. More efforts should be made to define the mechanisms and develop effective vaccines and therapies. (Hepatobiliary Pancreat Dis Int 2010; 9:584-592)

Transcriptional Analysis of Immune-Related Genes in Dendritic Cells from Hepatitis B Surface Antigen (Hbsag)-Positive Transgenic Mice and Regulation of Fc Gamma Receptor IIB by HBsAg-anti-HBs Complex.

Immune Response Against Hepatitis B Virus Induced by HBsAg Recombinant Adenovirus-Transduced Dendritic Cells in BALB/c Mice

Study on the Immune Response Induced by Hbcag Gene-Modified Dendritic Cells in Hepatitis B Virus Transgenic Mice

Immunostimulatory activities of dendritic cells loaded with adenovirus vector carrying HBcAg/HBsAg.

Recognition of HBV antigens and HBV DNA by dendritic cells.

Immunization with HBsAg-Fc Fusion Protein Induces a Predominant Production of Th1 Cytokines and Reduces HBsAg Level in Transgenic Mice.

[A Study of Immune Response to HBsAg Mediated by CD4+ Memory T Lymphocytes in Immunized HBV Transgenic Mice].

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

HBsAg Inhibits TLR9-mediated Activation and IFN-α Production in Plasmacytoid Dendritic Cells

HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Different Immune Conditions.

Immunization with Lentiviral Vector‑modified Dendritic Cells Encoding Ubiquitinated Hepatitis B Core Antigen Promotes Th1 Differentiation and Antiviral Immunity by Enhancing P38 MAPK and JNK Activation in HBV Transgenic Mice.

HBsAg Inhibits IFN-α Production in Plasmacytoid Dendritic Cells Through TNF-α and IL-10 Induction in Monocytes.

The Study on the Relationship Between Expression of B7-H1 on HBV Transgenic Mice and Immune Toler-Ance to HBV

Hepatitis B E Antigen Perturbs the LPS-stimulated Production of Inflammatory Cytokines by Mononuclearderived Dendritic Cells

Differential Regulation of Host Genes Including Hepatic Fatty Acid Synthase in HBV-transgenic Mice.

Gene-expression Profiles of a Hepatitis B Small Surface Antigen-Secreting Cell Line Reveal Upregulation of Lymphoid Enhancer-Binding Factor 1

Study on T Cellular Immune Response to Large-dose HBsAg in Transgenic Mice

Hepatitis B Virus Core Antigen Epitopes Presented By Hla-A2 Single-Chain Trimers Induce Functional Epitope-Specific Cd8(+) T-Cell Responses In Hla-A2.1/Kb Transgenic Mice

MicroRNA Differential Expression Profiles in DC after the Stimulation of HBsAg

Effect of CpG-ODN and HBsAg on the Phenotype and Function of Monocyte-Derived Dendritic Cells in Chronic Hepatitis B

Identification of Key Genes and Pathways Associated with Different Immune Statuses of Hepatitis B Virus Infection.